http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014042416-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64565acdcc52331729793a894d422711
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
filingDate 2013-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f711b8189febb106e776777c009e496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9810377b8887d7bc5764722e55baa498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_396e85362ba515238c35a0246036dd0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5576afc39688df73c511b73afbdca765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aafe43b4f7af4c8b535d7c841730eba8
publicationDate 2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014042416-A1
titleOfInvention Oral composition containing dapoxetin-free base
abstract The present invention provides a pharmaceutical preparation comprising dapoxetin or a pharmaceutically acceptable salt thereof, and more particularly to a pharmaceutical preparation in a film formulation, wherein the pharmaceutical preparation is administered by being dissolved or disintegrated in the mouth and is characterized in that it has a dapoxetin-free base as an active ingredient.
priorityDate 2012-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008035358-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1225881-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120068678-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012053006-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011129519-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71353

Total number of triples: 30.